Vanguard Global Advisers »

Neurogene shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $98k 4.9k 20.16

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Neurogene

Samsara BioCapital
Redmile Group
Casdin Capital
Rtw Investments
EcoR1 Capital
BlackRock
Baker Bros. Advisors
Trails Edge Capital Partners
Balyasny Asset Management
Toronto-Dominion Bank
Vanguard Group
Jennison Associates
Arrowpoint Asset Management
Vanguard Capital Management
Dr. Jeffrey R. Jay, M.D.

View all funds holding Neurogene